|
Post by kite on Nov 29, 2019 9:01:12 GMT -5
WESTLAKE VILLAGE, Calif., Nov. 29, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will be featured as a presenting company at the Piper Jaffray 31st Annual Healthcare Conference on Tuesday, December 3, 2019 at 3:30 p.m. (ET) at the Lotte New York Palace in New York City. Presenting from the Company will be its Chief Executive Officer, Michael Castagna. The presentation will be webcast live. Interested parties can access a link to the live webcast of the presentation from the News & Events section of the Company's website at www.mannkindcorp.com. The webcast replay will remain available for 14 days following the live presentation. www.globenewswire.com/news-release/2019/11/29/1954057/0/en/MannKind-Corporation-to-Present-at-the-Piper-Jaffray-31st-Annual-Healthcare-Conference.html
|
|
|
Post by georgethenight2 on Nov 29, 2019 9:11:13 GMT -5
WESTLAKE VILLAGE, Calif., Nov. 29, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will be featured as a presenting company at the Piper Jaffray 31st Annual Healthcare Conference on Tuesday, December 3, 2019 at 3:30 p.m. (ET) at the Lotte New York Palace in New York City. Presenting from the Company will be its Chief Executive Officer, Michael Castagna. The presentation will be webcast live. Interested parties can access a link to the live webcast of the presentation from the News & Events section of the Company's website at www.mannkindcorp.com. The webcast replay will remain available for 14 days following the live presentation. www.globenewswire.com/news-release/2019/11/29/1954057/0/en/MannKind-Corporation-to-Present-at-the-Piper-Jaffray-31st-Annual-Healthcare-Conference.htmlWas this conference on the schedule for MNKD? Or out of the blue?
|
|
|
Post by kite on Nov 29, 2019 9:12:13 GMT -5
WESTLAKE VILLAGE, Calif., Nov. 29, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will be featured as a presenting company at the Piper Jaffray 31st Annual Healthcare Conference on Tuesday, December 3, 2019 at 3:30 p.m. (ET) at the Lotte New York Palace in New York City. Presenting from the Company will be its Chief Executive Officer, Michael Castagna. The presentation will be webcast live. Interested parties can access a link to the live webcast of the presentation from the News & Events section of the Company's website at www.mannkindcorp.com. The webcast replay will remain available for 14 days following the live presentation. www.globenewswire.com/news-release/2019/11/29/1954057/0/en/MannKind-Corporation-to-Present-at-the-Piper-Jaffray-31st-Annual-Healthcare-Conference.htmlWas this conference on the schedule for MNKD? Or out of the blue? Out of the blue maybe? I just got the notification about this event this morning from MannKind
|
|
|
Post by boytroy88 on Nov 29, 2019 9:24:20 GMT -5
Was this conference on the schedule for MNKD? Or out of the blue? Out of the blue maybe? I just got the notification about this event this morning from MannKind Isn't this conference another one of those companies go to in search of funding?
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 29, 2019 10:26:02 GMT -5
Out of the blue maybe? I just got the notification about this event this morning from MannKind Isn't this conference another one of those companies go to in search of funding? It's two fold....MNKD wants to get their story out. They want the street to know they have turned the company around and things are on the right track. Piper also handles capital raises so the more they know the easier it is for them to find investors to handle the raise.
|
|
|
Post by agedhippie on Nov 29, 2019 11:06:10 GMT -5
Looking at the way the PR is phrased I think it's about changing the focus from Afrezza towards selling a delivery service with UTHR as an example.
|
|
|
Post by matt on Nov 29, 2019 11:33:43 GMT -5
Out of the blue maybe? I just got the notification about this event this morning from MannKind Isn't this conference another one of those companies go to in search of funding? 100% of all financial conferences sponsored by investment banks are promotional activities that the bank hopes will result in fees, either from fund raises executed on behalf of growth companies that need capital or merger/acquisition fees from more established companies. Nobody does anything for free, and investment banks have to get fees to stay in business and this is just how the game is played. The good news is that Piper is a notch up from H.C. Wainwright (aka Rodman & Renshaw) and some of the other banks MNKD has previously been using. Whether Piper can generate enough interest to pull off a deal for MNKD remains to be seen. If too many conferences go by with no deals coming to fruition, companies don't get invited back by the sponsor.
|
|
|
Post by nemzter on Nov 29, 2019 11:45:04 GMT -5
WESTLAKE VILLAGE, Calif., Nov. 29, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will be featured as a presenting company at the Piper Jaffray 31st Annual Healthcare Conference on Tuesday, December 3, 2019 at 3:30 p.m. (ET) at the Lotte New York Palace in New York City. Presenting from the Company will be its Chief Executive Officer, Michael Castagna. The presentation will be webcast live. Interested parties can access a link to the live webcast of the presentation from the News & Events section of the Company's website at www.mannkindcorp.com. The webcast replay will remain available for 14 days following the live presentation. www.globenewswire.com/news-release/2019/11/29/1954057/0/en/MannKind-Corporation-to-Present-at-the-Piper-Jaffray-31st-Annual-Healthcare-Conference.htmlWas this conference on the schedule for MNKD? Or out of the blue? It was timed so Mikey can attend the Philly vs NY game next Monday night, on the 9th. Well done Mikey, well done indeed.
|
|
|
Post by mnkdfann on Nov 29, 2019 12:45:25 GMT -5
The good news is that Piper is a notch up from H.C. Wainwright (aka Rodman & Renshaw) and some of the other banks MNKD has previously been using. Whether Piper can generate enough interest to pull off a deal for MNKD remains to be seen. If too many conferences go by with no deals coming to fruition, companies don't get invited back by the sponsor. FWIW, Mannkind has attended previous editions of the Piper Jaffray Annual Health Care Conference already, several times in the past. At editions 20, 24, 25, and 26 (from a quick google search) anyway. Possibly others as well.
|
|
|
Post by awesomo on Nov 29, 2019 13:07:42 GMT -5
So this is the first one for Mike then...
|
|
|
Post by bababooey on Nov 29, 2019 13:20:15 GMT -5
Correct me if I am wrong, but wasn't the last conference held by Piper Jaffray followed by a secondary offering a few months later? It seems the focus of this conference is to attract potential investors. And why do they need investors? For dilution? From my recollection the price was pumped up prior to the last couple offerings.
|
|
|
Post by letitride on Nov 30, 2019 21:28:01 GMT -5
Correct me if I am wrong, but wasn't the last conference held by Piper Jaffray followed by a secondary offering a few months later? It seems the focus of this conference is to attract potential investors. And why do they need investors? For dilution? From my recollection the price was pumped up prior to the last couple offerings. Warrants expire, price gets pumped to $10 for an offering and I execute my calls for a Happy New Year. Looks like a win, win to me.
|
|
|
Post by careful2invest on Dec 2, 2019 22:58:34 GMT -5
Correct me if I am wrong, but wasn't the last conference held by Piper Jaffray followed by a secondary offering a few months later? It seems the focus of this conference is to attract potential investors. And why do they need investors? For dilution? From my recollection the price was pumped up prior to the last couple offerings. Warrants expire, price gets pumped to $10 for an offering and I execute my calls for a Happy New Year. Looks like a win, win to me. As much as I would love to see that be the case, I wouldn’t hold my breath on that one. GLTA True Longs
|
|